Early onset of immunological heparin-induced thrombocytopenia in acute myocardial infarction

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 1, 1997, Pages 13-15

  Suzuki, S ^a   Koide, M ^a   Sakamoto, S ^a   Yamamoto, S ^a   Matsuo, M ^a   Fujii, E ^a   Matsuo, T ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

acute myocardial infarction; antibody to platelet factor 4 heparin complex; heparin; heparin induced thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030967494     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199701000-00003     Document Type: Article

References (14)

1. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96.
2. Shulman NR, Reid DM. Platelet immunology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. 3rd ed. Philadelphia: Lippincott, 1994; 414-468.
3. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-88.
4. Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost 1994; 71: 247-251.
5. Koide M, Yamamoto S, Matsuo M, Suzuki S, Arima N, Matsuo T. Anticoagulation for heparin-induced thrombocytopenia with spontaneous platelet aggregation in a patient requiring haemodialysis. Nephrol Dial Transplant 1995; 10: 2137-2140.
6. Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996; 28: 82-85.
7. Chong BH, Pitney WR, Castaldi PA. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis and platelet aggregation. Lancet 1982; ii: 1246-1248.
8. Sakamoto S, Hirase T, Suzuki S, et al. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty. Thromb Haemost 1995; 74: 801-802.
9. Matsuo T, Kario K, Chikahira Y, Nakao K, Yamada, T. Treatment of heparin-induced thrombocytopenia by use of argatroban. A synthetic thrombin. Br J Haematol 1992; 82: 627-629.
10. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 1992; 67: 545-549.
11. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-989.
12. Modesti PA, Colella A, Cecioni I, et al. Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation. Am Heart J 1995; 129: 873-879.
13. Sobel M, Salzman EW, Davies GC, et al. Circulating platelet products in unstable angina pectoris. Circulation 1981; 63: 300-306.
14. Tahara A, Yasuda M, Itagane H, et al. Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease. Am Heart J 1991; 122: 986-992.